Daniels Eric Joseph Insider Trades

Insider Trading History

Track insider trading activity for Daniels Eric Joseph. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Plus Therapeutics
Plus Therapeutics PSTV
Chief Development Officer
Holding Value $115k 20,000 shares
Last Trade
Apr 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$292k 40,000 shares
$7.30
$5.74
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $83.5k 31,741 shares
Last Trade
Apr 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.81k 929 shares
$1.95
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $85.9k 32,670 shares
Last Trade
Mar 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.8k 19,600 shares
$1.98
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $68.7k 26,137 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$481 238 shares
$2.02
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $69.4k 26,375 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.5k 15,543 shares
$2.93
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $48.9k 18,577 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64k 14,710 shares
$4.35
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $29.5k 11,222 shares
Last Trade
Jun 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.57k 1,431 shares
$5.29
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $329k 125,000 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 125,000 shares
$5.11
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $68k 25,838 shares
Last Trade
Mar 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$358k 10,400 shares
$34.47
$2.63
AB Active ETFs- AB Corporate Bond ETF
AB Active ETFs- AB Corporate Bond ETF EYEG
Chief Development Officer
Holding Value $529k 15,000 shares
Last Trade
Oct 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.3k 15,000 shares
$1.95
$35.26
AB Active ETFs- AB Corporate Bond ETF
AB Active ETFs- AB Corporate Bond ETF EYEG
Chief Development Officer
Holding Value $882k 25,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.8k 25,000 shares
$1.95
$35.26
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $65.8k 25,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.89M 25,000 shares
$275.58
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $25k 9,520 shares
Last Trade
Oct 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.82M 9,520 shares
$716.40
$2.63
AB Active ETFs- AB Corporate Bond ETF
AB Active ETFs- AB Corporate Bond ETF EYEG
Chief Development Officer
Holding Value $1.76M 50,000 shares
Last Trade
Oct 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.5k 50,000 shares
$1.99
$35.26
AB Active ETFs- AB Corporate Bond ETF
AB Active ETFs- AB Corporate Bond ETF EYEG
Chief Development Officer
Holding Value $336k 9,520 shares
Last Trade
Oct 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9k 9,520 shares
$1.99
$35.26
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Chief Development Officer
Holding Value $132k 50,000 shares
Last Trade
Oct 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.8M 50,000 shares
$716.40
$2.63

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up